Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 4 Active not recruiting 3 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 48 Calcium Dobesilate 20 Bortezomib 20 Lenalidomide 19 Melphalan 16 daratumumab 11 Cyclophosphamide 11 pomalidomide 10 elotuzumab 8 carfilzomib 8 dexamethasone acetate 7 pembrolizumab 6 ixazomib 6 fludarabine phosphate 6 dexamethasone 21-phosphate 6 venetoclax 5 selinexor 5 fludarabine 5 auricularum 5 Filgrastim 5 liposomal doxorubicin 4 Thalidomide 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Magnetic Resonance Spectroscopy 4 Whole-Body Irradiation 3 Vorinostat 3 Simvastatin 3 Nivolumab 3 Mycophenolic Acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Diphenhydramine × Plasma cell × Clear all

NCT05013437 2024-04-02

AHCT

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡